Bill W. Adolfsen, Ph.D. is a registered patent attorney and associate at Andrus Intellectual Property Law. He represents a wide range of universities, biotechnology, and pharmaceutical companies in intellectual property matters.
Bill focuses his practice on domestic and international patent prosecution, strategic patent portfolio development, post-grant proceedings, and enforcement. He also provides counseling related to patentability, freedom-to-operate, non-infringement, and patent validity.
Bill brings a unique combination of technical, business, and litigation experience to his life sciences patent practice. As an experienced molecular biologist, Bill’s technical experience covers a number of scientific fields including synthetic biology, genome engineering, molecular biology, neuroscience, immunology, antibody engineering, genetics, and bioenergy. His doctoral research at MIT focused on the molecular mechanisms underlying synaptic transmission. Results from his work have appeared in several scientific journals, including the Journal of Cell Biology, PNAS, Neuron, and Science.
Bill has also worked as both a scientist and business development manager in the biotechnology industry. After graduate school, Bill worked at an early-stage synthetic biology company focused on commercializing small and large synthetic DNA constructs, therapeutic antibodies, biobased industrial chemicals, and biofuels.
Prior to joining Andrus, Bill was a scientific advisor and patent litigation associate at a national law firm where he was involved in litigating patent disputes surrounding both small molecule pharmaceuticals and protein-based therapeutics.
Bill received a bachelor of science degree in biotechnology from Rutgers University in 1999, a doctorate degree in molecular biology from MIT in 2005, and a juris doctor degree from the University of Wisconsin Law School in 2013.
Bill is admitted to practice law before the Supreme Court of Wisconsin, the U.S. District Courts for the Eastern and Western Districts of Wisconsin, and the U.S. Patent and Trademark Office.